Objective: The authors measured cardiac index in unstable patients after cardiac surgery with the Pressure Recording Analytic Method (PRAM) and compared it with the reference method of thermodilution (ThD) with the pulmonary artery catheter; using the hypothesis that there were no significant differences between the 2 methods.
T HE PRIMARY GOAL of hemodynamic therapy in highrisk patients is the evaluation of tissue perfusion and oxygenation to avoid ischemic and cardiac complications. Cardiovascular monitoring can predict hemodynamic derangements and optimize treatment. The ability to recognize and provide adequate treatment to alter cardiac index (CI) is one of the most important cornerstones of hemodynamic assessment. [1] [2] [3] The thermodilution method (ThD) with the pulmonary artery catheter (PAC) is the gold standard for the estimation of CI, but its use increasingly has been criticized because of its risks, and there is an increasing focus on the development of noninvasive methods. 2 Most-Care (powered by the pressure-recording analytic method [PRAM] ; Vytech HealthTM, Padova, Italy) is a minimally invasive cardiac output (CO) monitor. It uses a pulse contour method for arterial pressure-derived continuous CI that requires no calibration. PRAM estimates CI from the analysis of the pressure wave profile, obtained from an arterial catheter, either radial or femoral. PRAM differs from other devices that use the analysis of the pressure profile curve for CI monitoring in that it uses perturbation, a process that considers all significant parts of the pulse-pressure wave and uses them to obtain the systemic impedance and other hemodynamic parameters. To perform it, PRAM samples at a rate of 1,000 Hz (high signal resolution) to preserve important information lost by the other pulse contour methods. [4] [5] [6] [7] PRAM is the first less invasive device that has been validated in patients with low-cardiac-output syndrome (LCOS) who are receiving inotropic drugs and/or an intraaortic balloon pump (IABP).
8 A previous study suggested that PRAM was not useful in patients with atrial fibrillation (AF). 9 The aim of this study was to confirm the accuracy and precision of PRAM in CI measurement as compared with ThD in high-risk patients with or without AF who were admitted to the intensive care unit (ICU) after cardiac surgery.
METHODS
The protocol was approved by the ethical committee and written consent was obtained from all participating subjects. The authors performed 94 measurements in 59 patients admitted to a postcardiac surgery ICU, for a total of 1,410 contemporary observations between PRAM and ThD. All enrolled patients had a PAC and either high-dose inotropic agents and/or an IABP because of postoperative LCOS developed after the end of the surgical intervention (defined as CI o2 L/min/m 2 after preload optimization). Preload was optimized before the inclusion in the study according to echocardiographic and pressure-related indices. All patients were mechanically ventilated in the supine position and monitored with an electocardiogram, a pulse oximeter, and an arterial pressure catheter. No patient was excluded because of artifacts. Exclusion criteria were the use of dopamine or dobutamine, o8 mg/kg/min, or the use of epinephrine or norepinephrine, o0.05 mg/kg/min, or by a CI Z4.5 L/min/m 2 . Each measurement consisted in 15 observations with ThD and 15 concomitant PRAM observations. Some patients had more than one measurement, performed on different days.
The pulmonary artery thermistor-tipped catheter (131MF7; Edwards Critical Care, Irvine, California) was inserted through an internal jugular vein and connected to the CI computer (Explorer, Edwards Critical Care, Irvine, California). Bolus thermodilution was performed with 10 mL of 5% glucose at room temperature injected by a power injector over about 3 seconds. In each patient, 5 consecutive injections of the thermal indicator were performed, and this 5-step procedure was repeated 3 times in succession. The overall measurement lasted approximately 8 minutes and included 15 observations (Fig. 1) . The highest and lowest ThD cardiac index observation of every train-of-5 consecutive injections was excluded, and the mean of the 3 remaining values was considered for analysis, as done by Scolletta et al.
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The arterial pressure catheter (20-G, 48-mm-long catheter; Angiocath; Abbott, Abbott Park, Illinois) was connected via a 3-way stopcock to MostCare (PRAM system; VYTEC Health, Padova, Italy). The same catheter was used for intensive care monitoring of the arterial blood pressure and for withdrawing arterial blood samples. Arterial pressure was measured after calibrating and zeroing to the midaxillary line. The pressure signal was filtered at 25 Hz to avoid resonance effects caused by the catheter-transducer system without degrading pressure wave amplitude. The investigators connected PRAM to the analog output of the monitoring system for the analysis of the arterial pressure wave and the subsequent blood flow computation. The authors recorded PRAM CI for 15 observations, at the same time as the 15 ThD injections. As PRAM is a beat-to-beat monitoring system, the mean CI of 12 consecutive beats was used. The highest and lowest PRAM cardiac index observation of every train-of-5 observation were excluded, and statistical analysis considered the mean of the 3 remaining values.
All data were analyzed with R 2.12.2 (Free Software Foundation, Boston, Massachusetts) and SAS 9.0 (SAS Institute Inc., Cary, North Carolina). The Kolmogorov-Smirnov and Shapiro-Wilk tests were used to check the normality distribution of the mean difference between PRAM and ThD. Continuous data were expressed as mean Ϯ standard deviation if not otherwise indicated. Cardiac output values were indexed to body surface area and referred to as CI. To investigate the equality between the 2 methods, the mixed linear model for repeated measures was applied. The Bland-Altman plot 11 was built to test the agreement between the methods, with bias and limits of agreement calculated as the mean difference between the 2 methods and the bias Ϯ1.96 standard deviation, respectively. The percentage of error was calculated as the limit of agreement (2.2 times the standard deviation of the bias) divided by the mean CO from the 2 methods, as proposed by Critchley and Critchley: 100 x (2.2 x SD of bias)/ [(meanThD-CO þ meanMostCare-CO)/2]. 12 
RESULTS
The hemodynamic characteristics and anthropometric parameters together with the use of IABP, cannulation site, and comorbidities are presented in Tables 1 and 2 . All patients required high doses of inotropic drugs. The mean of the total CI measurements was 2.94 Ϯ 0.67 L/min/m 2 with PRAM and 2.95 Ϯ 0.63 L/min/m 2 with ThD, with no significant difference according to the linear mixed models analysis.
The PRAM and ThD techniques were similar in unstable patients without AF (48 patients and 77 measurements, 82% of total measurements); the mean bias between the 2 techniques was 0.047 Ϯ 0.395 L/min/m 2 with lower and upper 95% limits of confidence of 0.74222 and -0.83814 L/min/m 2 and a percentage error of 29% (Fig 2A) .
No agreement between PRAM and ThD was found in unstable patients with AF (11 patients and 17 measurements, 18% of total measurements); the mean bias between the 2 techniques was 0.195 Ϯ 0.885 L/min/m 2 with lower and upper 95% limits of confidence of 1.96684 and -1,57648 L/min/m 2 and a percentage error of 69% (Fig 2B) . Notably, all patients with AF had radial arterial monitoring.
Notably, the PRAM and ThD techniques were similar in the 15 unstable patients (for a total of 19 measurements) who had an IABP (percentage error of 30%) and in the 8 patients (for a total of 12 measurements) with continuous veno-venous hemofiltration (percentage error of 23%).
DISCUSSION
In this study, the authors confirmed good agreement between PRAM and ThD in critically ill patients without AF receiving high doses of inotropes and/or an IABP after cardiac surgery. This confirmed a previous report suggesting that PRAM is similar to ThD in patients who receive high doses of catecholamines after cardiac surgery, 8 and another study that suggested no differences between PRAM and ThD methods in patients with an IABP. 10 It is worth noting that the reliability of PRAM is not significantly affected by changes in arterial waveform morphology caused by inflation and deflation of the IABP and that patients with high doses of inotropic drugs show agreement between PRAM and ThD.
The measurement of flow generated by the cardiovascular system is a milestone in the hemodynamic monitoring of critically ill patients. Measuring continuous CI may prevent delay in diagnosis and therapy of significant hemodynamic CARDIAC INDEX ASSESSMENT changes. It is increasingly clear that targeted preemptive approach to the management of hemodynamics in the perioperative period, using the help of a noninvasive or invasive hemodynamic monitoring, might reduce morbidity and mortality for high-risk surgical patients. 13 The less or completely noninvasive methods, both with and without calibration, have introduced the possibility of continuous monitoring with no risk of complication related to the device insertion.
PRAM is a less invasive pulse contour method, which obtains CI values from the curve of blood pressure and without calibration or central venous catheterization. It provides a beatto-beat monitoring of CI through the arterial pressure signal detection. It is based on analysis of the pressure profile curve measured at high frequency (1,000 Hz) and recognizing peaks in systole and diastole and the points representing the dicrotic notch. These points are evaluated with the trend of the curve according to the physical principles of perturbation, to obtain the impedance of the system and hemodynamic variables. This allows a determination of beat-to-beat cardiac index, during both the systolic and diastolic blood pressure, collecting the signal recorded with an arterial catheter placed in the radial or femoral artery. 7 The purpose of this study was to evaluate the reliability of CI measurements by PRAM in patients with an IABP and/or high doses of inotropic drugs after cardiac surgery. To study the accuracy and precision of the PRAM, measures of CI were compared with those obtained by the method of thermodilution with a PAC, which is currently the standard method of reference.
The present data are in agreement with those of other groups, suggesting that the technique is reliable for the determination of CI during and after cardiac surgery and during noncardiac surgery. [14] [15] [16] [17] [18] [19] [20] [21] [22] In particular, in an early work, 7 PRAM was reliable in hemodynamically stable patients with CI between 1.65 and 3.91 L/min/m 2 who were undergoing diagnostic right and left heart catheterization before aortic or mitral valve surgery, coronary artery bypass graft, and correction of idiopathic cardiomyopathy. PRAM later was compared with ThD during cardiac surgery, perioperatively, and during cardiopulmonary bypass, showing agreement in low-risk patients. Other settings that were investigated included obese patients (in this case the method did not give encouraging results) 20 and pediatric patients (for whom the use of PRAM is considered useful). 21 A recent study by Scolletta et al 22 confirmed the data obtained earlier about the adequacy of PRAM as an important complementary method in the management of patients with ventricular mechanical assistance. PRAM also seems to provide satisfactory data in patients supported by other external devices, such as continuous hemofiltration. 23 Overall, PRAM showed good accuracy in CI measurements, with only 1 recent prospective study questioning the reliability of the PRAM technology for the determination of CO in postoperative cardiac surgery patients. 24 Compared with the study by Paarmann et al, there are some differences: in this study the authors enrolled a larger number of patients; for each patient, the number of measurements was greater; all patients were 
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unstable and supported by inotropes and/or an IABP; finally, they included only patients without complications (no continuous veno-venous hemofiltration, no arrhythmias). Both studies used the Bland Altman analysis. 24 The most frequently used pulse contour monitors available on the market are: FloTrac (Edwards Lifesciences, Irvine, California), PiCCO (PULSION Medical Systems AG, Munich, Germany), LiDCOrapid (LiDCO Ltd., London, England), and PRAM/MostCare (VYTEC Health, Padova, Italy). To the best of the authors' knowledge, only 2 studies found agreement between a less invasive device and ThD in hemodynamically unstable patients (those who really need continuous monitoring).
8, 16 Both studies compared PRAM with ThD and documented an agreement between the 2 methods in patients without AF. Notably, no direct comparison exists between PRAM and other methods.
Compared with previous work, 8,9 the authors carried out 15 ThD and 15 PRAM observations for each patient measurement, eliminating the highest and lowest values for each series of 5 and then averaging the 3 results to increase accuracy and reduce the stochastic error inherent in the methods, and more patients were enrolled. Furthermore, in the present manuscript, the authors studied 2 different subgroups of unstable patients, with or without AF, and confirmed the agreement only in the non-AF group of unstable patients. The authors previously detailed the possible reasons of non-agreement between PRAM and ThD in patients with AF, 9 and it is worth noting that even ThD is less precise in patients with AF. 25 Some limitations are present in the study. Not all measurements were made on the same postoperative day and, therefore, were not a perfect comparison of similar clinical situations, but it should be emphasized that measurements never were performed after the third day after the placement of the PAC. The authors enrolled a heterogenous cohort of patients, and this could have created a bias in sampling because patients had different causes of low cardiac output syndrome, but it should be noted that the results could be applied to the whole population with high doses of inotropic drugs after cardiac surgery. The authors did not perform a proper power analysis, but the study should be considered large when compared with similar published manuscripts. On the contrary, the findings in the subpopulations of patients with IABP, renal replacement therapy, and AF are not supported by an adequate sample size. The variability observed in this study could be, at least in part, attributed to the different type of cannulation (radial or femoral); a discrepancy between radial and femoral noninvasive CI monitoring was noted in other monitors that use the analysis of pressure profile curve. 26 All of the patients were mechanically ventilated, and the findings are applicable only to this population.
CONCLUSION
Cardiac index measurements performed with PRAM and with ThD after cardiac surgery showed a good agreement in hemodynamically unstable patients with high doses of inotropes and/or an IABP in patients in sinus rhythm, but not in those with AF. 
